1,283
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA OIP5-AS1 regulates smoke-related chronic obstructive pulmonary disease via targeting micro RNA -410-3p/IL-13

, , , & ORCID Icon
Pages 11664-11676 | Received 02 Sep 2021, Accepted 26 Oct 2021, Published online: 07 Dec 2021

References

  • Lareau SC, Fahy B, Meek P, et al. Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 2019 Jan 1;199(1): P1–p2.
  • Kim SH, Hong JH, Yang WK, et al. Herbal combinational medication of Glycyrrhiza glabra, Agastache rugosa Containing Glycyrrhizic Acid, Tilianin inhibits neutrophilic lung inflammation by affecting CXCL2, Interleukin-17/STAT3 signal pathways in a murine model of COPD. Nutrients. 2020 Mar 27;12:4.
  • Esquinas C, Janciauskiene S, Gonzalo R, et al. Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis. 2017;12:3381–3390.
  • Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med. 2020 Aug 4;173(3):Itc17–itc32.
  • Qi X, Chen H, Fu B, et al. LncRNAs NR-026690 and ENST00000447867 are upregulated in CD4(+) T cells in patients with acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:699–711.
  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017 May 13;389(10082):1931–1940.
  • Celli BR, Wedzicha JA, Drazen JM. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 2019 Sep 26;381(13):1257–1266.
  • Hattab Y, Alhassan S, Balaan M, et al. Chronic obstructive pulmonary disease. Crit Care Nurs Q. 2016 Apr-Jun;39(2):124–130.
  • Poulet C, Njock MS, Moermans C, et al. Exosomal long non-coding RNAs in lung diseases. Int J Mol Sci. 2020 May 19;21:10.
  • Song J, Wang Q, LncRNA ZL. MIR155HG contributes to smoke-related chronic obstructive pulmonary disease by targeting miR-128-5p/BRD4 axis. Biosci Rep. 2020 Mar 27;40(3). DOI:10.1042/BSR20192567.
  • Hu TJ, Huang HB, Shen HB, et al. Role of long non-coding RNA MALAT1 in chronic obstructive pulmonary disease. Exp Ther Med. 2020 Sep;20(3):2691–2697.
  • Niu X, Pu S, Ling C, et al. lncRNA Oip5-as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR-29a to activate the SIRT1/AMPK/PGC1α pathway. Cell Prolif. 2020 Jun;53(6):e12818.
  • Deng J, Deng H, Liu C, et al. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2. Biomed Pharmacothe. 2018 Feb;98:102–110.
  • Cai XJ, Huang LH, Zhu YK, et al. LncRNA OIP5‑AS1 aggravates house dust mite‑induced inflammatory responses in human bronchial epithelial cells via the miR‑143‑3p/HMGB1 axis. Mol Med Rep. 2020 Dec;22(6):4509–4518.
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017 Mar 1;195(5):557–582.
  • Liu P, Zhang H, Zeng H, et al. LncRNA CASC2 is involved in the development of chronic obstructive pulmonary disease via targeting miR-18a-5p/IGF1 axis. Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211028072.
  • Zhou F, Cao C, Chai H, et al. Circ-HACE1 aggravates cigarette smoke extract-induced injury in human bronchial epithelial cells via regulating toll-like receptor 4 by sponging miR-485-3p. Int J Chron Obstruct Pulmon Dis. 2021;16:1535–1547.
  • Zhao S, Lin C, Yang T, et al. Expression of long non-coding RNA LUCAT1 in patients with chronic obstructive pulmonary disease and its potential functions in regulating cigarette smoke extract-induced 16HBE cell proliferation and apoptosis. J Clin Lab Anal. 2021 Jul;35(7):e23823.
  • Yang P, Han J, Li S, et al. miR-128-3p inhibits apoptosis and inflammation in LPS-induced sepsis by targeting TGFBR2. Open Med (Wars). 2021;16(1):274–283.
  • Xiaoling G, Shuaibin L, Kailu L. MicroRNA-19b-3p promotes cell proliferation and osteogenic differentiation of BMSCs by interacting with lncRNA H19. BMC Med Genet. 2020 Jan 9;21(1):11.
  • Liu K, Zhou S, Liu J, et al. Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy. Drug Des Devel Ther. 2019;13:3117–3126.
  • Nylund P, Atienza Párraga A, Haglöf J, et al. A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma. Cell Death Dis. 2021 Feb 12;12(2):167.
  • Liu J, Jiang M, Deng S, et al. miR-93-5p-containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage. Mol Ther Nucleic Acids. 2018 Jun 1;11:103–115.
  • Ma J, Zhang X, Zhang H, et al. lncRNA MEG3 suppresses the progression of ankylosis spondylitis by regulating the Let-7i/SOST axis. Front Mol Biosci. 2020;7:173.
  • Zhang Q, Wu G, Guo S, et al. Effects of tristetraprolin on doxorubicin (Adriamycin)-induced experimental kidney injury through inhibiting IL-13/STAT6 signal pathway. Am J Transl Res. 2020;12(4):1203–1221.
  • Jin G, Chen Z, Zhang J, et al. Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism. Biosci Rep. 2018 Oct 31;38(5). DOI:10.1042/BSR20180905.
  • Zhang Y, Lin P, Hong C, et al. Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array. Cytokine. 2018 Nov;111:342–349.
  • Pilato E, Manzo R, Comentale G. Pulmonary embolism and Sars-Cov-2 infection: a new indication for surgical pulmonary endarterectomy? Heart Lung. 2020 Jul-Aug;49(4):352.
  • Cau R, Bassareo PP, Mannelli L, et al. Imaging in COVID-19-related myocardial injury. Int J Cardiovasc Imaging. 2021 Apr;37(4):1349–1360.
  • Li Y, Yin Z, Fan J, et al. The roles of exosomal miRNAs and lncRNAs in lung diseases. Signal Transduct Target Ther. 2019;4:47.
  • Liang Z, Tang F. The potency of lncRNA MALAT1/miR-155/CTLA4 axis in altering Th1/Th2 balance of asthma. Biosci Rep. 2020 Feb 28;40(2). DOI:10.1042/BSR20190397.
  • Zhou AY, Zhao YY, Zhou ZJ, et al. Microarray analysis of long non-coding RNAs in lung tissues of patients with COPD and HOXA-AS2 promotes HPMECs proliferation via notch1. Int J Chron Obstruct Pulmon Dis. 2020;15:2449–2460.
  • Gál Z, Gézsi A, Semsei ÁF, et al. Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases. J Transl Med. 2020 Nov 10;18(1):422.
  • Wang M, Sun X, Yang Y, et al. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p. Thorac Cancer. 2018 Aug;9(8):939–949.
  • Yuan Y, Liao H, Pu Q, et al. miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer. Signal Transduct Target Ther. 2020 Jun 12;5(1):85.
  • Jin R, Hu S, Liu X, et al. Intranasal instillation of miR‑410 targeting IL‑4/IL‑13 attenuates airway inflammation in OVA‑induced asthmatic mice. Mol Med Rep. 2019 Feb;19(2):895–900.
  • Wang Y, Jiao T, Fu W, et al. miR-410-3p regulates proliferation and apoptosis of fibroblast-like synoviocytes by targeting YY1 in rheumatoid arthritis. Biomed Pharmacothe. 2019 Nov;119:109426.
  • Ge H, Yan Z, Zhu H, et al. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson’s disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway. Exp Mol Pathol. 2019 Aug;109:16–24.
  • Vázquez Y, González L, Noguera L, et al. Cytokines in the respiratory airway as biomarkers of severity and prognosis for respiratory syncytial virus infection: an update. Front Immunol. 2019;10:1154.
  • Wang YQ, Liao Q, Tang SH, et al. Gubenzhike recipe ameliorates respiratory mucosal immunity in mice with chronic obstructive pulmonary disease through upregulation of the γδT lymphocytes and KGF levels. Evid Based Complement Alternat Med. 2020;2020:3056797.